5M, trading at S$0.03 on the SES. This SniperIQ fundamentals page covers Singapore Institute of Advanced Medicine Holdings's valuation, profitability (net margin -156.1%), revenue (S

What is Singapore Institute of Advanced Medicine Holdings's P/E ratio?

Singapore Institute of Advanced Medicine Holdings's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Singapore Institute of Advanced Medicine Holdings?

Singapore Institute of Advanced Medicine Holdings runs a net profit margin of -156.1%, a gross margin of -42.4%, and an operating margin of -130.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Singapore Institute of Advanced Medicine Holdings generate?

Singapore Institute of Advanced Medicine Holdings reported revenue of S

Does Singapore Institute of Advanced Medicine Holdings pay a dividend?

Singapore Institute of Advanced Medicine Holdings does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Singapore Institute of Advanced Medicine Holdings financially healthy?

Singapore Institute of Advanced Medicine Holdings carries a debt-to-equity ratio of 1.32x and a current ratio of 0.15x, with a market beta of 0.05. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Singapore Institute of Advanced Medicine Holdings a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Singapore Institute of Advanced Medicine Holdings (9G2) the key facts are: market cap S

5M, revenue S

Track Singapore Institute of Advanced Medicine Holdings's full fundamentals live

Get Singapore Institute of Advanced Medicine Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.